Showing results (151-160 of 204) with videos related to

Sort By:
Pageof 21
Molecular Pain|October 4, 2017
Peripheral and orofacial pain sensation is unaffected by the loss of p39Michaela Prochazkova, Bradford Hall, Minghan Hu, et al.
The American Journal of Cardiology|February 21, 1989
Lisinopril for severe congestive heart failureB F Uretsky, J A Shaver, C S Liang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 13, 2001
Neuronal cyclin-dependent kinase 5 activity is critical for survivalT Tanaka, Veeranna, T Ohshima, et al.
The Journal of Biological Chemistry|August 20, 2010
A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylationYa-Li Zheng, Niranjana D Amin, Ya-Fang Hu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 4, 2008
Cyclin-dependent kinase 5 phosphorylation of human septin SEPT5 (hCDCrel-1) modulates exocytosisNiranjana D Amin, Ya-Li Zheng, Sashi Kesavapany, et al.
Cornea|July 1, 1990
Histopathology of human keratorefractive lenticulesK S Pokorny, K R Kenyon, C Swinger, et al.
Biopharmaceutics & Drug Disposition|January 16, 1998
Pharmacokinetics and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteersJ J Zhao, J D Rogers, S D Holland, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|May 5, 2017
Qualitative Slow Blood Flow in Lower Extremity Deep Veins on Doppler Sonography: Quantitative Assessment and Preliminary Evaluation of Correlation With Subsequent Deep Venous Thrombosis Development in a Tertiary Care Oncology CenterCorey T Jensen, Antoun Chahin, Veral D Amin, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein KinasesB K Binukumar, Steven L Pelech, Catherine Sutter, et al.
Pageof 21